Teligent Pharma recalls
Teligent Pharma has 63 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 30 Mar 2022. 5 are still ongoing. The most frequent reason is potency & assay.
Total recalls63since 2019
Last 12 months0reported
Class I35% of total
Ongoing5latest 30 Mar 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 3 5%Class II 49 78%Class III 11 17%
Why teligent pharma is recalled
Product types
By year
Ongoing teligent pharma recalls
5 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL) recalledLidocaine Hydrochloride | Teligent Pharma | Potency & Assay | Nationwide |
| Drug | CLASS II | Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL) recalledLidocaine Hydrochloride | Teligent Pharma | Potency & Assay | Nationwide |
| Drug | CLASS I | Lidocaine Hydrochloride Topical Solution recalled by Teligent Pharma | Teligent Pharma | Foreign Material | Nationwide |
| Drug | CLASS II | Erythromycin Topical Solution recalled by Teligent Pharma | Teligent Pharma | Packaging Defects | Nationwide |
| Drug | CLASS II | Flurandrenolide Ointment recalled by Teligent Pharma | Teligent Pharma | Potency & Assay | Nationwide |
All teligent pharma recalls, newest first
63 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.